A quantitative comparison of rates of phagocytosis and digestion of apoptotic cells by macrophages from normal (BALB/c) and diabetes-prone (NOD) mice

Journal of Applied Physiology

Volumn 104, Issue 1, 2008, Pages 157-169

  Marée, Athanasius F M ^a   Komba, Mitsuhiro ^b   Finegood, Diane T ^b   Edelstein Keshet, Leah ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b SIMON FRASER UNIVERSITY   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Autoimmune diabetes; Digestion rate; Engulfment rate; Macrophage phagocytosis; Nod mice

Indexed keywords

INSULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PHAGOCYTOSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 38349066143     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00514.2007     Document Type: Article

References (41)

1. Akaike H. Information theory as an extension of the maximum likelihood principle. In: Second International Symposium on Information Theory, edited by Petrov BN, Csaki F. Budapest: Akademiai Kiado, 1973, p. 267-281.
2. Alleva DG, Pavlovich RP, Grant C, Kaser SB, Beller DI. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice. Diabetes 49: 1106-1115, 2000.
3. Asano K, Miwa M, Miwa K, Hanayama R, Nagase H, Nagata S, Tanaka M. Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice. J Exp Med 200: 459-467, 2004.
4. Bell CW, Jiang W, Reich CF, Pisetsky DS. The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291: C1318-C1325, 2006.
5. Camner P, Lundborg M, Låstbom L, Gerde P, Gross N, Jarstrand C. Experimental and calculated parameters on particle phagocytosis by alveolar macrophages. J Appl Physiol 92: 2608-2616, 2002.
6. Choi JJ, Reich CF, Pisetsky DS. Release of DNA from dead and dying lymphocyte and monocyte cell lines in vitro. Scand J Immunol 60: 159-166, 2004.
7. Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RAS, Earp HS, Matsushima G, Reap EA. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196: 135-140, 2002.
8. Dahlén E, Dawe K, Ohlsson L, Hedlund G. Dendritic cells and macrophages are the first and major producers of TNF-α in pancreatic islets in the nonobese diabetic mouse. J Immunol 160: 3585-3593, 1998.
9. Delovitch TL, Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7: 727-738, 1997.
10. Devendra D, Liu E, Eisenbarth GS. Type 1 diabetes: recent developments. BMJ 328: 750-754, 2004.
11. Erwig LP, Gordon S, Walsh GM, Rees AJ. Previous uptake of apoptotic neutrophils or ligation of integrin receptors downmodulates the ability of macrophages to ingest apoptotic neutrophils. Blood 93: 1406-1412, 1999.
12. Freiesleben De Blasio B, Bak P, Pociot F, Karlsen AE, Nerup J. Onset of type 1 diabetes: a dynamical instability. Diabetes 48: 1677-1685, 1999.
13. Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE, Kalden JR, Herrmann M. Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 9: 173-187, 2006.
14. Gaipl US, Munoz LE, Grossmayer G, Lauber K, Franz S, Sarter K, Voll RE, Winkler T, Kuhn A, Kalden J, Kern P, Herrmann M. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 28: 114-121, 2007.
15. Gallucci S, Lolkema M, Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5: 1249-1255, 1999.
16. Georgiou HM, Constantinou D, Mandel TE. Prevention of autoimmunity in nonobese diabetic (NOD) mice by neonatal transfer of allogeneic thymic macrophages. Autoimmunity 21: 89-97, 1995.
17. Gordon S. The role of the macrophage in immune regulation. Res Immunol 149: 685-688, 1998.
18. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum 41: 1241-1250, 1998.
19. Höglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 189: 331-339, 1999.
20. Jun HS, Yoon CS, Zbytnuik L, Van Rooijen N, Yoon JW. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 189: 347-358, 1999.
21. Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, Yoshikawa H, Nagata S. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443: 998-1002, 2006.
22. Licht R, Jacobs CWM, Tax WJM, Berden JHM. No constitutive defect in phagocytosis of apoptotic cells by resident peritoneal macrophages from pre-morbid lupus mice. Lupus 10: 102-107, 2001.
23. Luppi P, Trucco M. Immunological models of type 1 diabetes. Horm Res 52: 1-10, 1999.
24. Mahaffy JM, Edelstein-Keshet L. Modeling cyclic waves of circulating T cells in autoimmune diabetes. SIAM J Appl Math 67: 915-937, 2007.
25. Marée AFM, Komba M, Dyck C, Łabeçki M, Finegood DT, Edelstein-Keshet L. Quantifying macrophage defects in type 1 diabetes. J Theor Biol 233: 533-551, 2005.
26. Marée AFM, Kublik R, Finegood DT, Edelstein-Keshet L. Modelling the onset of Type 1 diabetes: can impaired macrophage phagocytosis make the difference between health and disease? Philos Transact A 364: 1267-1282, 2006.
27. Mathis D, Vence L, Benoist C. β-Cell death during progression to diabetes. Nature 414: 792-798, 2001.
28. McIlroy D, Tanaka M, Sakahira H, Fukuyama H, Suzuki M, Yamamura K, Ohsawa Y, Uchiyama Y, Nagata S. An auxiliary mode of apoptotic DNA fragmentation provided by phagocytes. Genes Dev 14: 549-558, 2000.
29. Mendes P. GEPASI: a software package for modelling the dynamics, steady states and control of biochemical and other systems. Comput Appl Biosci 9: 563-571, 1993.
30. Mendes P. Biochemistry by numbers: simulation of biochemical pathways with Gepasi 3. Trends Biochem Sci 22: 361-363, 1997.
31. Mendes P, Kell DB. Non-linear optimization of biochemical pathways: applications to metabolic engineering and parameter estimation. Bioinformatics 14: 869-883, 1998.
32. Motulsky HJ, Christopoulos A. Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting. San Diego, CA: GraphPad Software, 2003.
33. O'Brien BA, Fieldus WE, Field CJ, Finegood DT. Clearance of apoptotic β-cells is reduced in neonatal autoimmune diabetes-prone rats. Cell Death Differ 9: 457-464, 2002.
34. O'Brien BA, Geng X, Orteu CH, Huang Y, Ghoreishi M, Zhang Y, Bush JA, Li G, Finegood DT, Dutz JP. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 26: 104-115, 2006.
35. O'Brien BA, Huang Y, Geng X, Dutz JP, Finegood DT. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51: 2481-2488, 2002.
36. Odaka C, Mizuochi T. Macrophages are involved in DNA degradation of apoptotic cells in murine thymus after administration of hydrocortisone. Cell Death Differ 9: 104-112, 2002.
37. Potter PK, Cortes-Hernandez J, Quartier P, Botto M, Walport MJ. Lupus-prone mice have an abnormal response to thioglycolate and an impaired clearance of apoptotic cells. J Immunol 170: 3223-3232, 2003.
38. Reefman E, De Jong MCJM, Kuiper H, Jonkman MF, Limburg PC, Kallenberg CGM, Bijl M. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? Arthritis Res Ther 8: R156, 2006.
39. Shimada A, Takei I, Maruyama T, Kasuga A, Kasatani T, Watanabe K, Asaba Y, Ishii T, Tadakuma T, Habu S, et al. Acceleration of diabetes in young NOD mice with peritoneal macrophages. Diabetes Res Clin Pract 24: 69-76, 1994.
40. Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT. Neonatal β-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 49: 1-7, 2000.
41. Trudeau JD, Kelly-Smith C, Verchere CB, Elliott JF, Dutz JP, Finegood DT, Santamaria P, Tan R. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J Clin Invest 111: 217-223, 2003.